Citadel Advisors’s Diebold Nixdorf DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
MCM
VCM
BPCM
Citadel Advisors's DBD Position: Q1 2026 in Review
Citadel Advisors increased its Diebold Nixdorf (DBD) stake by 36% in Q1 2026, buying an estimated $2.18M and bringing the position to 113,071 shares worth $8.53M. The position accounts for ﹤0.01% of the portfolio, ranked #3471.
Citadel Advisors first reported a position in DBD in Q3 2023 and has held it in 9 quarters since. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.
- Citadel Advisors held 113,071 shares of Diebold Nixdorf worth $8.53M as of Q1 2026.
- Citadel Advisors bought 29,652 Diebold Nixdorf shares in Q1 2026, an estimated $2.18M.
- Diebold Nixdorf made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3471 holding.
- Citadel Advisors first reported a position in Diebold Nixdorf in Q3 2023 and has held it in 9 quarters since.
- 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.